Effect of heparin on coronary arterial patency after thrombolysis with tissue plasminogen activator in acute myocardial infarction

Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.

R B Sleight, Peter Sleight, Sarah Parish et al. · PubMed · 1988 · 2.9K citations

Medicine, Cardiology, Internal Medicine +9

Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial Infarction

Marcus A. DeWood, Julie Spores, Robert N. Notske et al. · New England Journal of Medicine · 1980 · 2.7K citations

Medicine, Cardiology, Internal Medicine +12

Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

James H. Chesebro, Genell L. Knatterud, Robert Roberts et al. · Circulation · 1987 · 2.3K citations · Full text

Medicine, Cardiology, Pharmacotherapy +13

TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTION

Robert G. Wilcox, Carl Olsson, Allan M. Skene et al. · The Lancet · 1988 · 1.2K citations

Medicine, Cardiology, Internal Medicine +10

Comparison of Invasive and Conservative Strategies after Treatment with Intravenous Tissue Plasminogen Activator in Acute Myocardial Infarction

New England Journal of Medicine · 1989 · 1K citations

Medicine, Cardiology, Surgery +13